產品描述: Selinexor (KPT-330) is an orally available, small molecule inhibitor of CRM1 (chromosome region maintenance 1 protein, exportin 1 or XPO1), with potential antineoplastic activity. |
靶點:
CRM1 |
參考文獻:
1.Tai YT, et al. Leukemia. 2014, 28(1), 155-165. 2.Etchin J, et al. Br J Haematol. 2013, 161(1), 117-127. |
溶解性:
Ethanol:38 mg/mL (85.7 mM) H2O:<1 mg/mL DMSO:82 mg/mL (185 mM) |
保存條件:
-20℃ |
配置溶液濃度參考:
|
1mg |
5mg |
10mg |
1 mM |
2.256 ml |
11.279 ml |
22.558 ml |
5 mM |
0.451 ml |
2.256 ml |
4.512 ml |
10 mM |
0.226 ml |
1.128 ml |
2.256 ml |
50 mM |
0.045 ml |
0.226 ml |
0.451 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |